Influencing tumor-associated macrophages in malignant melanoma with monoclonal antibodies

The application of monoclonal antibodies (mAbs) for the treatment of melanoma has significantly improved the clinical management of this malignancy over the last decade. Currently approved mAbs for melanoma enhance T cell effector immune responses by blocking immune checkpoint molecules PD-L1/PD-1 a...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Rebecca, Osborn, Gabriel, Mukhia, Bipashna, Laddach, Roman, Willsmore, Zena, Chenoweth, Alicia, Geh, Jenny L C, MacKenzie Ross, Alastair D, Healy, Ciaran, Barber, Linda, Tsoka, Sophia, Sanz-Moreno, Victoria, Lacy, Katie E, Karagiannis, Sophia N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543025/
https://www.ncbi.nlm.nih.gov/pubmed/36211808
http://dx.doi.org/10.1080/2162402X.2022.2127284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9543025/
https://www.ncbi.nlm.nih.gov/pubmed/36211808
http://dx.doi.org/10.1080/2162402X.2022.2127284

Ejemplares similares